If a patient exhibits prolonged bleeding times despite normal platelet count after taking a new medication, which mechanism of platelet aggregation is most likely inhibited?

💡 Explanation

Platelet aggregation requires fibrinogen bridging via glycoprotein IIb/IIIa receptors; therefore, inhibiting this interaction prevents proper clot formation, because the receptor binding is blocked. Thromboxane A2 synthesis, vWF binding and degranulation initiate aggregation, rather than mediate the final crosslinking.

• If a patient chronically overuses NSAIDs like ibuprofen, which consequence becomes likely regarding localized inflammation resolution?
• Why does plasma osmolality sharply increase in a patient undergoing dialysis when the dialysate's sodium concentration is transiently set too high?
• A researcher investigates the effects of aggregate formation on nerve cell function in Alzheimer's. Which mechanism explains why intracellular tau protein aggregates impair axonal transport in neurons?
• Why does antidiuretic hormone (ADH) secretion rapidly decrease if a dehydrated patient receives an intravenous infusion of hypotonic saline solution, which temporarily lowers plasma osmolality?
• What distinguishes the follicular phase from the luteal phase concerning hormone regulation?
• If gene therapy successfully restores function to retinal pigment epithelium cells in a patient with age-related macular degeneration, which consequence follows regarding waste removal from photoreceptor cells?